DTIL · Precision Biosciences Inc
$8.85
+0.13 (+1.49%)
At close · Aug 21
Market Cap
$244.27M
Shares
27.60M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-07-27 | 2026-07-23 | |
| 8-K | 2026-07-01 | — | |
| 8-K | 2026-06-16 | 2026-06-10 | |
| Investor Event Transcript | 2026-06-03 | 2025-11-30 | |
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-26 | 2026-05-21 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-08 | 2026-05-21 | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-02-11 | — | |
| 8-K | 2026-01-13 | 2026-01-12 | |
| Investor Event Transcript | 2025-11-30 | — | |
| 8-K | 2025-11-12 | 2025-11-10 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-09-02 | 2025-08-26 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-03 | 2025-05-28 | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-15 | 2025-05-28 | |
| 8-K | 2025-03-26 | — | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-03-07 | 2025-03-04 | |
| 8-K | 2025-01-29 | 2025-01-23 | |
| 8-K | 2025-01-08 | 2025-01-06 | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-10-24 | — | |
| 8-K | 2024-09-12 | 2024-09-09 | |
| 8-K | 2024-09-03 | — | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-06-10 | 2024-06-04 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-25 | 2024-06-04 | |
| 8-K | 2024-04-16 | 2024-04-11 | |
| 8-K | 2024-03-27 | — | |
| 10-K | 2024-03-27 | 2023-12-31 |
Showing 1–50 of 154 filings
Key facts
CIK
1357874
CUSIP
74019P207
13F (30d)
89 filings
88 filers
Visit website
Investor relations